Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68353-23-1

Post Buying Request

68353-23-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68353-23-1 Usage

Description

14-Formyldihydrorutaecarpine is a novel alkaloid compound that has been identified for its potential antioxidant properties. It is derived from natural sources and has demonstrated the ability to inhibit the formation of oxygen radicals, particularly through the action of human neutrophils. This unique characteristic positions 14-formyldihydrorutaecarpine as a promising candidate for various applications in different industries, particularly in the realm of health and medicine.

Uses

Used in Pharmaceutical Industry:
14-Formyldihydrorutaecarpine is used as a potential antioxidant agent for its ability to inhibit oxygen radical formation. This property makes it a valuable component in the development of treatments and therapies aimed at combating oxidative stress-related conditions and diseases.
Used in Nutraceutical Industry:
In the nutraceutical sector, 14-formyldihydrorutaecarpine is used as a dietary supplement or functional ingredient to support overall health and well-being. Its antioxidant effects can contribute to the maintenance of a balanced immune system and the prevention of cell damage caused by free radicals.
Used in Cosmetic Industry:
14-Formyldihydrorutaecarpine can be utilized in cosmetic products as an antioxidant agent to protect the skin from environmental stressors and promote skin health. Its ability to neutralize oxygen radicals may help in reducing signs of aging, inflammation, and other skin-related issues.
Used in Agricultural Industry:
In agriculture, 14-formyldihydrorutaecarpine may be employed as a natural antioxidant to improve the shelf life and quality of produce. Its application can help in reducing post-harvest losses and maintaining the nutritional value of agricultural products.

Check Digit Verification of cas no

The CAS Registry Mumber 68353-23-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,3,5 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 68353-23:
(7*6)+(6*8)+(5*3)+(4*5)+(3*3)+(2*2)+(1*3)=141
141 % 10 = 1
So 68353-23-1 is a valid CAS Registry Number.

68353-23-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 14-formyl-13b,14-dihydrorutaecarpine

1.2 Other means of identification

Product number -
Other names 14-formyl-8,13,13b,14-tetrahydro-7H-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68353-23-1 SDS

68353-23-1Downstream Products

68353-23-1Relevant articles and documents

Studies of Rutaecarpine and Related Quinazolinocarboline Alkaloids

Bergman, Jan,Bergman, Solveig

, p. 1246 - 1255 (2007/10/02)

Quinazolinocarboline alkaloids, e.g., rutaecarpine (1), can readily be synthesized by treating tryptamine with 2-(trifluoromethyl)-4H-3,1-benzoxazin-4-one (quickly generated in situ from trifluoroacetic anhydride (TFAA) and 2H-3,1-benzoxazine-2,4(1H)-dione.The product formed, 3--2-(trifluoromethyl)-4-(3H)-quinazolinone (5), is then cyclized (HCl/HOAc) to 13b-(trifluoromethyl)-13b,14-dihydrorutaecarpine (6), whereupon CF3H is eliminated by treatment with base.The sequence can conveniently be performed as a three-reaction one-pot procedure giving rutaecarpine (1) in 99percent yield within 3h.The approach can readily be extended to the synthesis of evodiamine (2), 13,13b-dehydroevodiamine (38a), and 13b,14-dihydrorutaecarpine (21).Thus treatment of 3--4(3H)-quinazolinone (19) with TFAA affected cyclization to 13b-(trifluoroacetyl)-13b,14-dihydrorutaecarpine (20), which can be readily hydrolyzed to 13b,14-dihydrorutaecarpine (21).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68353-23-1